Fig. 6 | Scientific Reports

Fig. 6

From: Development and validation of a basement membrane inflammatory response gene signature in lung adenocarcinoma

Fig. 6

Evaluation of treatment responsiveness for high group scores patients. Compared to the low- risk group, patients with high group scores showed significantly lower IC50 to treatment drugs docetaxel (A), ERK_6604 (B), Gefitinib (C), Luminespib (D), Sapitinib (E), SCH772984 (F), WIKI4 (G). (H, I) Showed that the high group scores more sensitive to immune checkpoint inhibitors, for PD1.

Back to article page